Servier presents its 2019/20 annual results, its R&D strategy and pipeline
All the news from Servier Group
Pascal Lemaire appointed Executive Vice President Finance
Neurological Diseases: Servier and X-Chem Sign Partnership Agreement
Servier to Acquire Agios Pharmaceuticals’ Oncology Business
Colorectal Cancer: Servier and Celsius Therapeutics collaborate for Target Discovery
Creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
Oncology: Servier launches its first treatment in the solid tumor field in Brazil
Servier partners with the Skolkovo Foundation to support most innovative biotech startups in Russia
Servier accelerates its digital transformation